Immediate Impact
38 standout
Citing Papers
Targeted protein degradation: advances in drug discovery and clinical practice
2024 Standout
Glioblastoma Therapy: Past, Present and Future
2024 Standout
Works of Hee‐Jin Cho being referenced
A multicenter, phase II trial of GC1118 , a novel anti‐EGFR antibody, for recurrent glioblastoma patients with EGFR amplification
2023
NTRK1 Fusion in Glioblastoma Multiforme
2014
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Hee‐Jin Cho | 51 | 40 | 24 | 29 | 15 | 119 | |
| Mariano Guardia Clausi | 79 | 44 | 19 | 21 | 12 | 232 | |
| Alessandra Pittaro | 50 | 37 | 87 | 27 | 18 | 223 | |
| Amy Vanko | 46 | 35 | 19 | 21 | 8 | 155 | |
| Gerhard Jungwirth | 90 | 47 | 30 | 52 | 13 | 167 | |
| Qing Zhou | 60 | 31 | 11 | 23 | 14 | 191 | |
| Lakshmikirupa Sundaresan | 104 | 15 | 17 | 20 | 18 | 199 | |
| Alexander Mensch | 57 | 19 | 25 | 14 | 19 | 181 | |
| L. Torres | 52 | 22 | 4 | 23 | 16 | 179 | |
| Minjie Fu | 78 | 57 | 8 | 31 | 19 | 190 | |
| Annekathrin Reinhardt | 54 | 104 | 28 | 22 | 16 | 158 |
All Works
Login with ORCID to disown or claim papers
Loading papers...